Lab technician looking into a microscope

ABPI: Changes to NICE methods ‘a catalyst for global investment’

Following publication of consultation on NICE’s methods for health technology evaluation, which the organisation has been undergoing a review of, The Association of the British Pharmaceutical Industry (ABPI) has welcomed the changes and the impacts they could have for the UK, it’s pharma industry and patients.

Driven by a desire to ensure access to the newest medicines by NHS patients at an affordable and firmly agreed pricing, the NICE processes dictate what medicines and treatments are and are not recommended for use within the health service.

In response to the consultation, Chief Executive of the ABPI, Richard Torbett, said: “The proposals set out in the consultation are a positive first step towards more NHS patients benefitting from the very latest medicines.

The consultation period will run until December 18, 2020, based around guaranteeing rapid access to clinically and cost effective health technologies for patients and their families, as well as supporting the NHS and life sciences industry.

Review of the current NICE methodology has come about to ensure that it remains as robust as possible in an ever-advancing modern world.

In particular, NICE have identified the following three areas as key topics of interest within the consultation:

  • Our proposals
  • How we’ve taken the evidence and considerations into account
  • Any potential effects and implications

"The changes outlined can also act as a catalyst for global investment, with the UK demonstrating its commitment to researching, developing and using new medicines and technologies.

"Implementation is also fully affordable due to voluntary scheme, which pharmaceutical companies are signed up to, and means that NHS spend on medicines is kept to an agreed and affordable level. We will work our membership on the next stage of the consultation.”

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all